Molecular Biology Research Associate (RA) /Senior Research Associate (Senior RA)
Responsibilities
- The individual will have several duties associated to the production of template DNA and mRNA to support both research activities and device development.
- In addition, the individual will participate in regular QC activities such as making NGS libraries, running sequencer.
- Under limited supervision, executes experiments as directed by the supervisor and communicates results as part of multi-disciplinary team(s).
- Applies relevant scientific principles and techniques to research problems.
- Maintains broad knowledge of state-of-the-art principles and techniques and may contribute to the identification of new project areas or technologies.
- May provide technical and scientific input to the project team or research leadership.
- Complies with all safety requirements.
- Documents experiments, follows and improves SOPs, and tracks samples using Nutcracker’s ELN and LIMS.
- Contributes effectively in a fast-paced environment.
Requirements
- The candidate should have 3+ years of research experience in an academic or industry setting and outstanding scientific and personal skills
- BS/MS in Biochemistry, Molecular/Cellular Biology or related fields
- Expertise in molecular biology skills including PCR/qPCR, invitro transcription, NGS library preparation and RNA handling knowledge.
- Experience in liquid handler, mammalian cell culture, transfection and setting up cellular assays would be beneficial.
- Familiarity with capillary electrophoresis, Flow cytometry and ELISA would be advantageous.
- Excellent written and verbal communication skills with ability to convey ideas and present data.Highly attentive to detail, flexible, and curious.
- Excellent interpersonal skills, adept at building cross functional relationships with different teams.
Similar Jobs
What We Do
Nutcracker Therapeutics is an RNA therapeutics company that has combined the power of advanced engineering with high-precision biosynthesis to deploy a complete RNA therapeutics platform. Armed with this high-tech advantage, we have developed a wholly owned pipeline of RNA therapeutic programs and established partnership initiatives with top clinical investigators at several leading institutions across the globe. With our platform’s ability to accelerate the development of life-changing RNA therapeutics, we seek to advance breakthrough RNA therapies at high velocity through all stages of development across a variety of indications. Our technology platform has the potential to significantly reduce costs and cycle times for RNA therapeutic development, with dramatic advantages in capacity scaling and point-of-care delivery over other RNA manufacturing approaches.








